Literature DB >> 22574715

Effects of an in-patient treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance in adolescents with severe obesity.

Carine Gueugnon1, Fabienne Mougin, Marie-Laure Simon-Rigaud, Jacques Regnard, Véronique Nègre, Gilles Dumoulin.   

Abstract

Adiponectin, the most abundant hormone produced by adipose tissue, circulates in 3 isoforms, including high molecular weight (HMW) adiponectin. The latter has been suggested to be a better predictor of metabolic disturbances and insulin resistance associated with obesity. This study investigated changes in total and HMW adiponectin, resistin, and homeostasis model assessment (HOMA) during a 9-month in-patient treatment program based on physical exercise and a balanced diet in 32 severely obese adolescents. Total and HMW adiponectin, resistin, and HOMA were measured at baseline (month 0) and during the program (months 3, 6, 9). In addition, a control group of 15 teenagers served as a reference for the baseline assessments. At baseline, HMW adiponectin was more markedly decreased in obese adolescents than total adiponectin, and both were lower than in controls. Conversely, resistin and HOMA were higher in obese adolescents. During the program, there was a significant change in body composition and improved insulin sensitivity among obese teenagers. In addition, HMW adiponectin and the ratio of HMW-to-total adiponectin increased throughout the study, whereas total adiponectin only increased up until the sixth month. On the contrary, resistin did not show any significant change. In obese adolescents, a long-term combination of aerobic exercise and a balanced diet, inducing change in body composition and improved insulin sensitivity, markedly increased HMW adiponectin compared with total adiponectin, without any change in resistin concentrations. Our results thus suggest that the determination of HMW adiponectin could be more useful than measurement of total adiponectin in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574715     DOI: 10.1139/h2012-045

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  9 in total

1.  Obstructive Sleep Apnea and Sleep Architecture in Adolescents With Severe Obesity: Effects of a 9-Month Lifestyle Modification Program Based on Regular Exercise and a Balanced Diet.

Authors:  Johanna Roche; Valérie Gillet; Frédéric Perret; Fabienne Mougin
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

2.  Are obstructive sleep apnea and sleep improved in response to multidisciplinary weight loss interventions in youth with obesity? A systematic review and meta-analysis.

Authors:  Johanna Roche; Laurie Isacco; Julie Masurier; Bruno Pereira; Fabienne Mougin; Jean-Philippe Chaput; David Thivel
Journal:  Int J Obes (Lond)       Date:  2020-01-07       Impact factor: 5.095

3.  Effect of probucol on insulin resistance in patients with non-diabetic chronic kidney disease.

Authors:  Rui Wang; Ri-Bao Wei; Yue Yang; Na Wang; Meng-Jie Huang; Cui-Ming Cao; Zi-Cheng Wang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  J Geriatr Cardiol       Date:  2015-09       Impact factor: 3.327

4.  Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions.

Authors:  Gillian E Walker; Roberta Ricotti; Marta Roccio; Stefania Moia; Simonetta Bellone; Flavia Prodam; Gianni Bona
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

5.  A novel prescription pedometer-assisted walking intervention and weight management for Chinese occupational population.

Authors:  Yingxiang Yu; Yiran Lv; Bin Yao; Liguang Duan; Xiaoyuan Zhang; Lan Xie; Cuiqing Chang
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

6.  Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin.

Authors:  Stefania Mai; Gillian E Walker; Roberta Vietti; Stefania Cattaldo; Chiara Mele; Lorenzo Priano; Alessandro Mauro; Gianni Bona; Gianluca Aimaretti; Massimo Scacchi; Paolo Marzullo
Journal:  Nutrients       Date:  2017-05-05       Impact factor: 5.717

7.  Beyond bariatric surgery and weight loss medicaments. A systematic review of the current practice in obesity rehabilitative inpatient programs in adults and pediatrics.

Authors:  Daniele Spadaccini; Silvia Guazzotti; Filipa Patricia Goncalves Correia; Tommaso Daffara; Sabrina Tini; Alessandro Antonioli; Gianluca Aimaretti; Paolo Marzullo; Marina Caputo; Valentina Antoniotti; Flavia Prodam
Journal:  Front Nutr       Date:  2022-09-29

8.  Current clinical evidence on pioglitazone pharmacogenomics.

Authors:  Marina Kawaguchi-Suzuki; Reginald F Frye
Journal:  Front Pharmacol       Date:  2013-11-26       Impact factor: 5.810

9.  Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats.

Authors:  Donghao Li; Jimin Zheng; Yiting Hu; Hongtao Hou; Shurong Hao; Na Liu; Yuzhen Wang
Journal:  Pharmacogn Mag       Date:  2017-11-13       Impact factor: 1.085

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.